Rosuvastatin Calcium Tablets , we have got ANDA approval since Oct,2016; now the sales amount is around USD10 million in US market; And we plan to register in EU market and South East Asia market and other markets.

Indication and Usage:

Rosuvastatin is indicated as adjunctive therapy to diet for the treatment of adult patients with Hypertriglyceridemia.

Rosuvastatin is indicated as an adjunct to diet for the treatment of adult patients with primary dysbetalipoproteinemia (Type III Hyperlipoproteinemia).

Rosuvastatin is indicated as adjunctive therapy to other lipid-lowering treatments (e.g., LDL apheresis) or alone if such treatments are unavailable to reduce LDL-C, Total-C, and ApoB in adult patients with homozygous familial hypercholesterolemia.

Rosuvastatin has not been studied in Fredrickson Type I and Vdyslipidemias.